Venture Capital Investors

Forbion Capital Partners

Forbion Capital Partners is a VC investing group that assists tech companies with financing and expertise.

Venture Investor Overview

Venture Investor
Forbion Capital Partners
Status
Active
Investor Type
Venture Capital
Activity Level
Industry Focus
AgTech
Biopharmaceutical
FoodTech
Healthcare Services
Life Sciences

Contact Information

Contact
Bart Bergstein
Title
Managing Partner
Mailing Address
Gooimeer 2-35
Naarden, 1411 DC
The Netherlands
Email Address

Background Information

Overview
At Forbion Capital Partners we invest in Life Sciences and Biomedical Technology companies developing world-class drugs and technologies, with a clear focus on product development. The Forbion team is specialized in the evaluation of late stage preclinical / early stage clinical development programs. We focus on companies that have innovative technologies and drug development programs with unique advantages over current treatments. Furthermore, we invest in biomedical technologies with a focus on interventional cardiology.
Profile
Forbion Capital Partners LinkedIn Company Profile
Social Media
Forbion Capital Partners Company Twitter Account
Company News
Forbion Capital Partners News
Facebook
Forbion Capital Partners on Facebook
YouTube
Forbion Capital Partners on YouTube
Last Transaction
9/12/2024

Transaction History

Our records indicate that Forbion Capital Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
9/12/2024
$19,000,000
9/11/2024
$14,000,000
8/27/2024
$100,000,000
7/31/2024
$60,000,000
7/3/2024
$170,000,000
6/18/2024
$190,000,000
5/21/2024
$120,000,000
5/20/2024
$65,000,000
4/22/2024
$75,000,000
3/21/2024
$175,000,000
3/19/2024
$157,000,000
2/29/2024
$28,265,000
1/30/2024
$32,780,000
1/24/2024
$81,130,000
10/25/2023
$245,000,000
10/25/2023
$245,000,000
10/24/2023
$85,000,000
10/17/2023
$8,484,000
6/6/2023
$65,397,000
5/15/2023
$44,000,000
4/17/2023
$78,978,000
4/17/2023
$78,933,000
3/16/2023
$12,500,000
3/7/2023
$112,000,000
11/22/2022
$49,000,000
10/17/2022
$69,000,000
9/28/2022
$68,000,000
3/24/2022
$87,900,000
10/18/2021
$100,000,000
1/20/2021
$2,300,000
9/9/2020
$35,000,000
8/11/2020
$115,000,000
4/4/2019
$50,000,000
10/26/2018
$80,000,000
3/14/2018
$19,000,000
9/11/2017
$55,000,000
7/26/2017
$55,000,000
9/7/2016
$16,879,575
6/16/2016
$24,779,700
2/17/2016
$15,000,000
1/7/2016
$60,000,000
9/25/2015
$30,000,000
9/4/2015
$17,600,000
5/12/2015
$38,000,000
1/27/2015
$10,876,000
3/11/2014
$27,000,000
9/30/2012
$14,378,100
5/16/2012
$35,000,000
4/24/2012
$25,000,000
3/8/2012
$21,500,000
12/31/2011
$8,584,000
11/30/2011
$30,000,000
4/20/2011
$30,000,000
5/12/2010
$20,000,000
3/16/2010
$12,000,000
3/12/2010
$35,000,000
5/20/2009
$42,500,000
3/30/2009
$40,000,000
11/24/2008
$35,200,000
9/30/2008
$16,500,200
4/15/2008
$24,500,000
12/31/2007
$15,500,000
12/13/2007
$44,000,000
12/4/2007
$24,000,000
7/9/2007
$22,000,000
11/1/2006
$25,000,000
6/30/2005
$6,700,000

 


Investor Contacts

Title
Name
Email & Social
General Partner
Marco Boorsma
  Marco Boorsma LinkedIn Profile  Marco Boorsma Twitter Account  Marco Boorsma News  Marco Boorsma on Facebook
General Partner
Dirk Kersten
  Dirk Kersten LinkedIn Profile  Dirk Kersten Twitter Account  Dirk Kersten News  Dirk Kersten on Facebook
Managing Partner
Geert-Jan Mulder
  Geert-Jan Mulder LinkedIn Profile  Geert-Jan Mulder Twitter Account  Geert-Jan Mulder News  Geert-Jan Mulder on Facebook
General Partner
Holger Reithinger
  Holger Reithinger LinkedIn Profile  Holger Reithinger Twitter Account  Holger Reithinger News  Holger Reithinger on Facebook
Managing Partner
Sander Slootweg
  Sander Slootweg LinkedIn Profile  Sander Slootweg Twitter Account  Sander Slootweg News  Sander Slootweg on Facebook
Partner
Sander van Deventer
  Sander van Deventer LinkedIn Profile  Sander van Deventer Twitter Account  Sander van Deventer News  Sander van Deventer on Facebook
Managing Partner
Martien van Osch
  Martien van Osch LinkedIn Profile  Martien van Osch Twitter Account  Martien van Osch News  Martien van Osch on Facebook

 


Funds

Our database includes the following fund closing(s) for Forbion Capital Partners. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Growth Equity
7/9/2020
$209,000,000
Forbion IV
7/11/2018
$315,000,000
Forbion Capital Fund III
4/12/2016
$208,000,000
Forbion Capital Fund II Co-invest Fund I
9/10/2015
$83,000,000

 


Portfolio Companies

Forbion Capital Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

Foragen Technologies Management | Forbion Growth Opportunities Fund II

 

Share this article

 


About Our Venture Capital Investor Database

This venture capital firm data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary